# Investors Title Co: financial statements, quarterly

ITIC · Nasdaq · CIK 720858 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/itic.md) · [Financials](/companies/itic/financials.md) · [Filings](/companies/itic/filings.md) · [Insiders](/companies/itic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/itic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.3](/filings/0000720858-24-000025.md) | [8.9 d](/filings/0000720858-26-000011.md) | [8.0](/filings/0000720858-25-000012.md) | [9.1](/filings/0000720858-25-000028.md) | [8.9](/filings/0000720858-25-000032.md) | [9.1 d](/filings/0000720858-26-000011.md) | [8.5](/filings/0000720858-26-000017.md) | [11.2](/filings/0000720858-26-000030.md) | [11.1](/filings/0000720858-25-000032.md) | [10.2 d](/filings/0000720858-26-000011.md) | [9.4](/filings/0000720858-26-000017.md) | [11.1](/filings/0000720858-26-000030.md) |
| Income tax | $m | [1.5](/filings/0000720858-24-000025.md) | [0.4 d](/filings/0000720858-26-000011.md) | [1.3](/filings/0000720858-25-000012.md) | [2.4](/filings/0000720858-25-000028.md) | [2.3](/filings/0000720858-25-000032.md) | [2.4 d](/filings/0000720858-26-000011.md) | [0.9](/filings/0000720858-26-000017.md) | [3.5](/filings/0000720858-26-000030.md) | [2.9](/filings/0000720858-25-000032.md) | [2.1 d](/filings/0000720858-26-000011.md) | [1.6](/filings/0000720858-26-000017.md) | [4.8](/filings/0000720858-26-000030.md) |
| Net income | $m | [7.1](/filings/0000720858-24-000025.md) | [5.8 d](/filings/0000720858-26-000011.md) | [4.5](/filings/0000720858-25-000012.md) | [8.9](/filings/0000720858-25-000028.md) | [9.3](/filings/0000720858-25-000032.md) | [8.4 d](/filings/0000720858-26-000011.md) | [3.2](/filings/0000720858-26-000017.md) | [12.3](/filings/0000720858-26-000030.md) | [12.2](/filings/0000720858-25-000032.md) | [7.5 d](/filings/0000720858-26-000011.md) | [6.1](/filings/0000720858-26-000017.md) | [14.6](/filings/0000720858-26-000030.md) |
| Diluted EPS | $ per share | [3.75](/filings/0000720858-24-000025.md) | not reported | [2.40](/filings/0000720858-25-000012.md) | [4.70](/filings/0000720858-25-000028.md) | [4.92](/filings/0000720858-25-000032.md) | not reported | [1.67](/filings/0000720858-26-000017.md) | [6.48](/filings/0000720858-26-000030.md) | [6.45](/filings/0000720858-25-000032.md) | not reported | [3.20](/filings/0000720858-26-000017.md) | [7.73](/filings/0000720858-26-000030.md) |
| Basic EPS | $ per share | [3.75](/filings/0000720858-24-000025.md) | not reported | [2.40](/filings/0000720858-25-000012.md) | [4.71](/filings/0000720858-25-000028.md) | [4.94](/filings/0000720858-25-000032.md) | not reported | [1.68](/filings/0000720858-26-000017.md) | [6.51](/filings/0000720858-26-000030.md) | [6.47](/filings/0000720858-25-000032.md) | not reported | [3.21](/filings/0000720858-26-000017.md) | [7.75](/filings/0000720858-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.4](/filings/0000720858-23-000024.md) | [24.0](/filings/0000720858-25-000007.md) | [21.6](/filings/0000720858-24-000007.md) | [26.7](/filings/0000720858-24-000020.md) | [25.5](/filings/0000720858-24-000025.md) | [24.7](/filings/0000720858-26-000011.md) | [27.6](/filings/0000720858-25-000012.md) | [29.7](/filings/0000720858-25-000028.md) | [22.8](/filings/0000720858-25-000032.md) | [20.8](/filings/0000720858-26-000030.md) | [26.7](/filings/0000720858-26-000017.md) | [20.5](/filings/0000720858-26-000030.md) |
| Total assets | $m | [332](/filings/0000720858-24-000025.md) | [331](/filings/0000720858-26-000011.md) | [329](/filings/0000720858-25-000012.md) | [340](/filings/0000720858-25-000028.md) | [352](/filings/0000720858-25-000032.md) | [334](/filings/0000720858-26-000011.md) | [334](/filings/0000720858-26-000017.md) | [346](/filings/0000720858-26-000030.md) | [363](/filings/0000720858-25-000032.md) | [363](/filings/0000720858-26-000030.md) | [362](/filings/0000720858-26-000017.md) | [380](/filings/0000720858-26-000030.md) |
| Total liabilities | $m | [79.2](/filings/0000720858-23-000024.md) | [79.0](/filings/0000720858-25-000007.md) | [75.5](/filings/0000720858-24-000007.md) | [78.5](/filings/0000720858-24-000020.md) | [80.7](/filings/0000720858-24-000025.md) | [81.8](/filings/0000720858-26-000011.md) | [79.4](/filings/0000720858-25-000012.md) | [79.6](/filings/0000720858-25-000028.md) | [85.3](/filings/0000720858-25-000032.md) | [94.8](/filings/0000720858-26-000030.md) | [88.7](/filings/0000720858-26-000017.md) | [93.6](/filings/0000720858-26-000030.md) |
| Shareholders' equity | $m | [253](/filings/0000720858-24-000025.md) | [252](/filings/0000720858-26-000011.md) | [254](/filings/0000720858-25-000028.md) | [262](/filings/0000720858-25-000032.md) | [271](/filings/0000720858-25-000032.md) | [252](/filings/0000720858-26-000030.md) | [254](/filings/0000720858-26-000030.md) | [266](/filings/0000720858-26-000030.md) | [278](/filings/0000720858-25-000032.md) | [268](/filings/0000720858-26-000030.md) | [273](/filings/0000720858-26-000030.md) | [287](/filings/0000720858-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.7 d](/filings/0000720858-24-000025.md) | [14.1 d](/filings/0000720858-26-000011.md) | [1.4](/filings/0000720858-25-000012.md) | [8.4 d](/filings/0000720858-25-000028.md) | [7.8 d](/filings/0000720858-25-000032.md) | [12.1 d](/filings/0000720858-26-000011.md) | [(0.1)](/filings/0000720858-26-000017.md) | [8.9 d](/filings/0000720858-26-000030.md) | [17.2 d](/filings/0000720858-25-000032.md) | [5.0 d](/filings/0000720858-26-000011.md) | [1.6](/filings/0000720858-26-000017.md) | [8.1 d](/filings/0000720858-26-000030.md) |
| Capital expenditure | $m | [1.6 d](/filings/0000720858-24-000025.md) | [2.6 d](/filings/0000720858-26-000011.md) | [2.2](/filings/0000720858-25-000012.md) | [2.1 d](/filings/0000720858-25-000028.md) | [1.7 d](/filings/0000720858-25-000032.md) | [1.3 d](/filings/0000720858-26-000011.md) | [1.3](/filings/0000720858-26-000017.md) | [1.6 d](/filings/0000720858-26-000030.md) | [1.3 d](/filings/0000720858-25-000032.md) | [1.3 d](/filings/0000720858-26-000011.md) | [1.1](/filings/0000720858-26-000017.md) | [1.9 d](/filings/0000720858-26-000030.md) |
| Dividends paid | $m | [0.9 d](/filings/0000720858-24-000025.md) | [8.4 d](/filings/0000720858-26-000011.md) | [0.9](/filings/0000720858-25-000012.md) | [0.9 d](/filings/0000720858-25-000028.md) | [0.9 d](/filings/0000720858-25-000032.md) | [27.3 d](/filings/0000720858-26-000011.md) | [0.9](/filings/0000720858-26-000017.md) | [0.9 d](/filings/0000720858-26-000030.md) | [0.9 d](/filings/0000720858-25-000032.md) | [17.3 d](/filings/0000720858-26-000011.md) | [0.9](/filings/0000720858-26-000017.md) | [0.9 d](/filings/0000720858-26-000030.md) |
| Share repurchases | $m | [0.0 d](/filings/0000720858-24-000025.md) | [0.0 d](/filings/0000720858-26-000011.md) | [1.1](/filings/0000720858-25-000012.md) | [0.0 d](/filings/0000720858-25-000028.md) | [0.0 d](/filings/0000720858-25-000032.md) | [0.0 d](/filings/0000720858-26-000011.md) | [0.0](/filings/0000720858-25-000012.md) | [0.0 d](/filings/0000720858-25-000028.md) | [0.0 d](/filings/0000720858-25-000032.md) | [0.0 d](/filings/0000720858-26-000011.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,897](/filings/0000720858-23-000024.md) | [1,897](/filings/0000720858-24-000007.md) | [1,896](/filings/0000720858-24-000020.md) | [1,891](/filings/0000720858-24-000025.md) | [1,889](/filings/0000720858-25-000012.md) | [1,886](/filings/0000720858-25-000028.md) | [1,893](/filings/0000720858-25-000032.md) | [1,895](/filings/0000720858-26-000017.md) | [1,894](/filings/0000720858-26-000030.md) | [1,894](/filings/0000720858-25-000032.md) | [1,894](/filings/0000720858-26-000017.md) | [1,894](/filings/0000720858-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,887,996 at 2026-07-28, from the cover of the [10-Q filed 2026-08-10](/filings/0000720858-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.